Methodology Protocol

You have free access to this content

Association between personal conflicts of interest and recommendations on medical interventions

  1. Andreas Lundh1,*,
  2. Anders W Jørgensen2,
  3. Lisa Bero3

Editorial Group: Cochrane Methodology Review Group

Published Online: 5 JUN 2013

DOI: 10.1002/14651858.MR000040


How to Cite

Lundh A, Jørgensen AW, Bero L. Association between personal conflicts of interest and recommendations on medical interventions (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: MR000040. DOI: 10.1002/14651858.MR000040.

Author Information

  1. 1

    Rigshospitalet, The Nordic Cochrane Centre, Copenhagen, Denmark

  2. 2

    Aarhus University Hospital, Otorhinolaryngology and Head & Neck Surgery, Aarhus, Denmark

  3. 3

    University of California San Francisco, Department of Clinical Pharmacy and Institute for Health Policy Studies, San Francisco, California, USA

*Andreas Lundh, The Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, 7811, Copenhagen, DK-2100, Denmark. al@cochrane.dk.

Publication History

  1. Publication Status: New
  2. Published Online: 5 JUN 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objectives are to investigate whether: 

  • authors of scientific opinion pieces with personal financial conflicts of interest related to drug, device or medical imaging companies are more likely to recommend the companies' products;
  • authors of clinical practice guidelines with personal financial conflicts of interest related to drug, device or medical imaging companies are more likely to recommend the companies' products;
  • drug or device advisory committee members with personal financial conflicts of interest related to drug or device companies are more likely to recommend the companies' products for approval;
  • formulary committee members with personal financial conflicts of interest related to drug companies are more likely to recommend the companies' products;
  • authors of scientific opinion pieces with other types of financial conflicts of interest related to a particular intervention are more likely to recommend the intervention.